MAPS donated $5,000 USD to Franz Vollenweider, M.D., University of Zurich, for his research with subjects from our Swiss MDMA/PTSD study. Dr. Vollenwieder evaluated all 12 subjects from the study before and after MDMA/PTSD treatment. The evaluations consisted of EEGs, startle-reflex tests and heart-rate variability, the results of which are related to the severity of PTSD. The analysis is almost complete and a paper is being written for publication. The physiological study cost more than $5,000; Dr. Vollenweider raised the rest of the funds elsewhere.
